Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Ho

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Physical Chemistry Letters|April 12, 2024
Influence of Selective Carbon 1s Excitation on Auger-Meitner Decay in the ESCA MoleculeA E A Fouda, V Lindblom, S H Southworth, et al.
Blood|November 8, 2001
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10R D Brown, B Pope, A Murray, et al.
Internal Medicine Journal|December 10, 2015
Practical management of myelofibrosis with ruxolitinibP J Ho, P Marlton, C Tam, et al.
Breast Cancer Research and Treatment|May 16, 2017
Risk of death from cardiovascular disease following breast cancer: a systematic reviewS A M Gernaat, P J Ho, N Rijnberg, et al.
Leukemia|April 23, 2016
Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeH Suen, R Brown, S Yang, et al.
Internal Medicine Journal|July 10, 2013
Health of adults living with a clinically significant haemoglobinopathy in New South Wales, AustraliaH J Crowther, R Lindeman, P J Ho, et al.
Scientific Reports|May 4, 2017
Risk of death from cardiovascular disease following breast cancer in Southeast Asia: a prospective cohort studyS A M Gernaat, P J Ho, N Rijnberg, et al.
Blood Cancer Journal|September 17, 2013
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceC Bryant, H Suen, R Brown, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Nature Communications|May 24, 2016
Hetero-site-specific X-ray pump-probe spectroscopy for femtosecond intramolecular dynamicsA Picón, C S Lehmann, C Bostedt, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Physical Chemistry Letters|April 12, 2024
Influence of Selective Carbon 1s Excitation on Auger-Meitner Decay in the ESCA MoleculeA E A Fouda, V Lindblom, S H Southworth, et al.
Blood|November 8, 2001
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10R D Brown, B Pope, A Murray, et al.
Internal Medicine Journal|December 10, 2015
Practical management of myelofibrosis with ruxolitinibP J Ho, P Marlton, C Tam, et al.
Breast Cancer Research and Treatment|May 16, 2017
Risk of death from cardiovascular disease following breast cancer: a systematic reviewS A M Gernaat, P J Ho, N Rijnberg, et al.
Leukemia|April 23, 2016
Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeH Suen, R Brown, S Yang, et al.
Internal Medicine Journal|July 10, 2013
Health of adults living with a clinically significant haemoglobinopathy in New South Wales, AustraliaH J Crowther, R Lindeman, P J Ho, et al.
Scientific Reports|May 4, 2017
Risk of death from cardiovascular disease following breast cancer in Southeast Asia: a prospective cohort studyS A M Gernaat, P J Ho, N Rijnberg, et al.
Blood Cancer Journal|September 17, 2013
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceC Bryant, H Suen, R Brown, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Nature Communications|May 24, 2016
Hetero-site-specific X-ray pump-probe spectroscopy for femtosecond intramolecular dynamicsA Picón, C S Lehmann, C Bostedt, et al.
Pageof 6